Evidence map›Paper›PMID 38224411›Full record

ReviewNetherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation2024

Embedding routine health care data in clinical trials: with great power comes great responsibility.

M Louis Handoko, Frances S de Man, Jasper J Brugts, Peter van der Meer, Hanneke F M Rhodius-Meester, Jeroen Schaap, H J Rik van de Kamp, Saskia Houterman, Dennis van Veghel, Alicia Uijl and 1 more

Abstract readReview
In one paragraph

Review in Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. The Dutch cardiomyopathy registry (DCR); rationale and registry design.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Diverging from the traditional RCT paradigm.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

M Louis HandokoDepartment of Cardiology, Amsterdam University Medical Centres, Amsterdam, The Netherlands. ml.handoko@amsterdamumc.nl.ORCID http://orcid.org/0000-0002-8942-7865
Frances S de ManDepartment of Pulmonary Medicine, Amsterdam University Medical Centres, Amsterdam, The Netherlands.
Jasper J BrugtsDepartment of Cardiology, Thorax Centre, Erasmus Medical Centre, University Medical Centre Rotterdam, Rotterdam, The Netherlands.
Peter van der MeerDepartment of Cardiology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
Hanneke F M Rhodius-MeesterDepartment of Internal Medicine, Geriatrics Section, Amsterdam University Medical Centres, Amsterdam, The Netherlands.
Jeroen SchaapDepartment of Cardiology, Amphia Hospital, Breda, The Netherlands.
H J Rik van de KampNetherlands Heart Registration, Utrecht, The Netherlands.
Saskia HoutermanNetherlands Heart Registration, Utrecht, The Netherlands.
Dennis van VeghelNetherlands Heart Registration, Utrecht, The Netherlands.
Alicia UijlDepartment of Cardiology, Amsterdam University Medical Centres, Amsterdam, The Netherlands.
Folkert W AsselbergsDepartment of Cardiology, Amsterdam University Medical Centres, Amsterdam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Randomised clinical trials (RCTs) are vital for medical progress. Unfortunately, 'traditional' RCTs are expensive and inherently slow. Moreover, their generalisability has been questioned. There is considerable overlap in routine health care data (RHCD) and trial-specific data. Therefore, integration of RHCD in an RCT has great potential, as it would reduce the effort and costs required to collect data, thereby overcoming some of the major downsides of a traditional RCT. However, use of RHCD comes with other challenges, such as privacy issues, as well as technical and practical barriers. Here, we give a current overview of related initiatives on national cardiovascular registries (Netherlands Heart Registration, Heart4Data), showcasing the interrelationships between and the relevance of the different registries for the practicing physician. We then discuss the benefits and limitations of RHCD use in the setting of a pragmatic RCT from a cardiovascular perspective, illustrated by a case study in heart failure.

Indexed as

Big dataCardiovascular diseasesHeart failurePragmatic clinical trialsRandomised controlled trials

Identifiers

PMID38224411
PMCPMC10884372

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.